Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036612 | 12603661 | 2 | F | 201603 | 20160830 | 20160728 | 20160901 | PER | US-PFIZER INC-2016356287 | PFIZER | 60.00 | YR | M | Y | 87.00000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036612 | 12603661 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 50 MG, AS NEEDED, 100 MG, CUTTING THE PILL IN HALF | 20895 | 50 | MG | FILM-COATED TABLET | |||||||
| 126036612 | 12603661 | 2 | I | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, AS NEEDED | 20895 | 100 | MG | FILM-COATED TABLET | |||||||
| 126036612 | 12603661 | 3 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 126036612 | 12603661 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY, ONE DAILY | 0 | 20 | MG | ||||||||
| 126036612 | 12603661 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 126036612 | 12603661 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, 2X/DAY | 0 | 800 | MG | BID | |||||||
| 126036612 | 12603661 | 7 | C | ROBAXIN | METHOCARBAMOL | 1 | Oral | 750 MG, 2X/DAY | 0 | 750 | MG | TABLET | BID | ||||||
| 126036612 | 12603661 | 8 | C | ROBAXIN | METHOCARBAMOL | 1 | 0 | TABLET | |||||||||||
| 126036612 | 12603661 | 9 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | Oral | 15 MG, 2X/DAY | 0 | 15 | MG | TABLET | BID | ||||||
| 126036612 | 12603661 | 10 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | UNK, 1X/DAY | 0 | TABLET | QD | ||||||||
| 126036612 | 12603661 | 11 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126036612 | 12603661 | 1 | Erectile dysfunction |
| 126036612 | 12603661 | 3 | Hypertension |
| 126036612 | 12603661 | 4 | Blood cholesterol abnormal |
| 126036612 | 12603661 | 5 | Gastrooesophageal reflux disease |
| 126036612 | 12603661 | 6 | Back pain |
| 126036612 | 12603661 | 7 | Back pain |
| 126036612 | 12603661 | 8 | Back injury |
| 126036612 | 12603661 | 9 | Anxiety |
| 126036612 | 12603661 | 10 | Coagulopathy |
| 126036612 | 12603661 | 11 | Prophylaxis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126036612 | 12603661 | Drug ineffective | |
| 126036612 | 12603661 | Drug interaction | |
| 126036612 | 12603661 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126036612 | 12603661 | 2 | 201603 | 0 | ||
| 126036612 | 12603661 | 10 | 201505 | 0 |